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The majority of large scale cell culture processes is performed in stirred tank bioreactors (STR) and process 
development employs scale down models of the same bioreactor type. However, for screening of clones or 
process conditions at even smaller scale, shake flasks (SF) represent the most widely used model. 
Occasionally, SF allow for robust processes that cannot be transferred to STR because sensitive cells cannot 
cope with mechanical stress in STR due to stirring and aeration. Orbital shaken bioreactors (OSB) are a 
valuable alternative to STR as the transfer from SF to OSB is simplified because the systems rely on the same 
basic principles for mixing and aeration (e.g., bubble-free surface gassing). In particular, high oxygen transfer 
rates and short mixing times combined with low shear stress can also be achieved in OSB. These benefits may 
be even more pronounced in high density culture processes. 
 
In this study, the SB10-X bioreactor (Kühner AG, Switzerland) was evaluated for the production of influenza A 
virus. Avian AGE1.CR.pIX cells (ProBioGen AG, Germany) were cultivated in the chemically defined medium 
CD-U3 (Biochrom-Merck, Germany) in 10 L single-use standard bags with 5 L initial working volume (w.v.) and 
70 rpm shaking frequency. For perfusion, either an alternating tangential flow system (ATF2, Repligen, 500 kDa 
cut-off) or a tangential flow filtration unit (TFF, Spectrum Labs, 0.2 µm cut-off) was used (Figure 1). After 
infection with influenza virus A/PR/8/34 (H1N1) at a MOI of 0.001, the w.v. was increased up to 9 L while 
perfusion was maintained, similarly to a hybrid perfusion fed-batch strategy previously proposed [1]. In addition, 
the shaking was increased to 90 rpm during virus production phase. 
 
Both retention devices were successfully coupled to the OSB and 
concentrations up to 50 x 106 cells/mL were obtained, typically with 
viabilities higher than 90%. We did not observe a decrease of the 
specific growth rate in the bioreactor system using either perfusion 
setup. Regarding virus production, we achieved similar or higher HA 
titers compared to cultivations of AGE1.CR cells in 1 L STR 
combined with ATF [2]. On average, the cell-specific virus yields 
(CSVY) obtained in the OSB cultivations were 2.2-fold higher 
compared to the best ATF cultivations in STR, and a CSVY of 3500 
virions/mL was achieved. A comparison between OSB runs in 
perfusion versus OSB batch revealed a CSVY 2.5-fold higher in 
perfusion, showing that the typical batch productivity was exceeded 
by far. On the other hand, infectious virus titers were usually lower 
in OSB and further experiments are necessary to better understand 
virus propagation in OSB in case live vaccine production is 
intended. 
To our knowledge, this is the first report on the application of the 
single-use OSB in perfusion mode and we demonstrate that the 
technology can be used successfully for virus production. 
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Figure 1. The SB10-X orbital shaken 
bioreactor was operated in perfusion 
mode coupled to ATF (A) or TFF (B) 
with a minimum working volume of 
5 L for the 10 L bag. A magnetic drive 
pump (Levitronix®) was used for 
recirculation in the TFF. 
 
